{"timestamp": 1771600346.57077, "value": {"ticker": "MREO", "company_name": "Mereo BioPharma Group plc", "short_name": "Mereo BioPharma Group plc", "sector": "Healthcare", "industry": "Biotechnology", "country": "United Kingdom", "market_cap": 66755744, "float_shares": 483434151, "shares_outstanding": 159131701, "short_ratio": 0.5, "short_percent_of_float": 0.115200005, "shares_short": 13042775, "shares_short_prior": 10517934, "insider_percent_held": 0.00962, "institution_percent_held": 0.50352, "total_cash": 48698000, "total_debt": 397000, "total_revenue": 500000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.734, "operating_margins": -90.678, "debt_to_equity": 0.852, "current_ratio": 8.711, "book_value": 0.293, "price_to_book": 1.4317405, "operating_cashflow": -32709000, "free_cashflow": -20145250, "price": 0.4195, "52w_high": 3.05, "52w_low": 0.2, "avg_volume": 15249531, "avg_volume_10d": 3633490, "full_time_employees": 36, "audit_risk": 0, "overall_risk": 0}}